Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline

Authors
Lass-Florl, C Dierich, MP Fuchs, D Semenitz, E Ledochowski, M
Citation
C. Lass-florl et al., Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline, CLIN INF D, 33(12), 2001, pp. 135-136
Citations number
8
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
33
Issue
12
Year of publication
2001
Pages
135 - 136
Database
ISI
SICI code
1058-4838(200112)33:12<135:AAACSO>2.0.ZU;2-D
Abstract
Three patients with premenstrual dysphoric disorder (PMDD) and recurrent vu lvovaginal candidiasis (VVC) underwent sertraline therapy (Tresleen, a sele ctive serotonin-reuptake inhibitor; Pfizer) for PMDD. During sertraline int ervention, patients had no recurrent episodes of acute VVC. Antifungal acti vity was observed for sertraline against various isolates of Candida specie s.